Clinical Trial Update: A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 mechanistic study of LY518674 effects on HDL cholesterol metabolism in metabolic syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• LY518674

Snippet

Sponsor: University of Pennsylvania | Conditions: Metabolic Syndrome X | Phase 2 | Status: COMPLETED